Publications

Link to Google Scholar profile

Publication list

Sort by: Date | Author | Title

Bak R, Dever DP, Porteus MH. CRISPR/Cas9 genome editing in human hematopoietic stem cells. Nature Protocols (Print). 2018;13(2):358-376. doi: 10.1038/nprot.2017.143
Bak RO, Gomez-Ospina N, Porteus MH. Gene Editing on Center Stage. Trends in Genetics. 2018;34(8):600-611. doi: 10.1016/j.tig.2018.05.004
Bak RO, Dever DP, Porteus MH. Therapeutic Genome Editing in Human Hematopoietic Stem and Progenitor Cells. In Genome Editing and Engineering: From TALENs, ZFNs and CRISPRs to Molecular Surgery. Cambridge University Press. 2018. p. 301-312 doi: 10.1017/9781316756300.022
Charlesworth CT, Camarena J, Cromer MK, Vaidyanathan S, Bak RO, Carte JM et al. Priming Human Repopulating Hematopoietic Stem and Progenitor Cells for Cas9/sgRNA Gene Targeting. Molecular Therapy - Nucleic Acids. 2018 Sept 7;12:89-104. doi: 10.1016/j.omtn.2018.04.017
Cromer MK, Vaidyanathan S, Ryan DE, Curry B, Lucas AB, Camarena J et al. Global Transcriptional Response to CRISPR/Cas9-AAV6-Based Genome Editing in CD34 Hematopoietic Stem and Progenitor Cells. Molecular Therapy. 2018;26(10):2431-2442. doi: 10.1016/j.ymthe.2018.06.002
Dalsgaard T, Kaadt CRC, Askou AL, Bak RO, Andersen PO, Hougaard D et al. Improved Lentiviral Gene Delivery to Mouse Liver by Hydrodynamic Vector Injection through Tail Vein. Molecular Therapy - Nucleic Acids. 2018 Sept 7;12:672-683. Epub 2018 Aug 6. doi: 10.1016/j.omtn.2018.07.005
Vakulskas CA, Dever DP, Rettig GR, Turk R, Jacobi AM, Collingwood MA et al. A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells. Nature Medicine. 2018;24(8):1216-1224. doi: 10.1038/s41591-018-0137-0
Bak RO, Porteus MH. CRISPR-Mediated Integration of Large Gene Cassettes Using AAV Donor Vectors. Cell Reports. 2017 Jul 18;20(3):750-756. doi: 10.1016/j.celrep.2017.06.064
Bak RO, Dever DP, Reinisch A, Cruz Hernandez D, Majeti R, Porteus MH. Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6. eLife. 2017 Sept 28;6:e27873. doi: 10.7554/eLife.27873
Dever DP, Bak RO, Reinisch A, Camarena J, Washington G, Nicolas CE et al. CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells. Nature. 2016 Nov 17;539(7629):384-389. doi: 10.1038/nature20134
Hnisz D, Weintraub AS, Day DS, Valton AL, Bak RO, Li CH et al. Activation of proto-oncogenes by disruption of chromosome neighborhoods. Science. 2016 Mar 25;351(6280):1454-1458. doi: 10.1126/science.aad9024
Hendel A, Bak RO, Clark JT, Kennedy AB, Ryan DE, Roy S et al. Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells. Nature Biotechnology. 2015 Jun 29. doi: 10.1038/nbt.3290
Bak RO, Hollensen AK, Mikkelsen JG. Managing MicroRNAs with Vector-Encoded Decoy-Type Inhibitors. Molecular Therapy. 2013 Aug;21(8):1478-85. doi: 10.1038/mt.2013.113
Bak R, Mikkelsen JG. miRNA sponges: soaking up miRNAs for regulation of gene expression. Wiley Interdisciplinary Reviews: RNA. 2013 Dec 23. doi: 10.1002/wrna.1213
Jakobsen MR, Bak RO, Andersen A, Berg RK, Jensen SB, Tengchuan J et al. IFI16 senses DNA forms of the lentiviral replication cycle and controls HIV-1 replication. Proceedings of the National Academy of Sciences (PNAS). 2013 Oct 23. doi: 10.1073/pnas.1311669110
Nascimento Lopes Primo M, Bak RO, Mikkelsen JG. Lentiviral vectors for cutaneous RNA managing. Experimental Dermatology Online. 2012;21(3):162-70. doi: 10.1111/j.1600-0625.2011.01436.x
Staunstrup NH, Sharma N, Bak RO, Svensson L, Petersen TK, Aarenstrup L et al. A Sleeping Beauty DNA transposon-based genetic sensor for functional screening of vitamin D3 analogues. BMC Biotechnology. 2011 Apr 7;11(1):33. doi: 10.1186/1472-6750-11-33